Fluorine in PDB 1bm7: Human Transthyretin (Prealbumin) Complex with Flufenamic Acid (2-[[3-(Trifluoromethyl)Phenyl]Amino] Benzoic Acid)
Protein crystallography data
The structure of Human Transthyretin (Prealbumin) Complex with Flufenamic Acid (2-[[3-(Trifluoromethyl)Phenyl]Amino] Benzoic Acid), PDB code: 1bm7
was solved by
T.Klabunde,
J.W.Kelly,
J.C.Sacchettini,
with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:
Resolution Low / High (Å)
|
8.00 /
2.00
|
Space group
|
P 21 21 2
|
Cell size a, b, c (Å), α, β, γ (°)
|
43.180,
85.320,
64.460,
90.00,
90.00,
90.00
|
R / Rfree (%)
|
18.9 /
25.1
|
Fluorine Binding Sites:
Pages:
>>> Page 1 <<<
Page 2, Binding sites: 11 -
12;
Binding sites:
The binding sites of Fluorine atom in the Human Transthyretin (Prealbumin) Complex with Flufenamic Acid (2-[[3-(Trifluoromethyl)Phenyl]Amino] Benzoic Acid)
(pdb code 1bm7). This binding sites where shown within
5.0 Angstroms radius around Fluorine atom.
In total 12 binding sites of Fluorine where determined in the
Human Transthyretin (Prealbumin) Complex with Flufenamic Acid (2-[[3-(Trifluoromethyl)Phenyl]Amino] Benzoic Acid), PDB code: 1bm7:
Jump to Fluorine binding site number:
1;
2;
3;
4;
5;
6;
7;
8;
9;
10;
Fluorine binding site 1 out
of 12 in 1bm7
Go back to
Fluorine Binding Sites List in 1bm7
Fluorine binding site 1 out
of 12 in the Human Transthyretin (Prealbumin) Complex with Flufenamic Acid (2-[[3-(Trifluoromethyl)Phenyl]Amino] Benzoic Acid)
Mono view
Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 1 of Human Transthyretin (Prealbumin) Complex with Flufenamic Acid (2-[[3-(Trifluoromethyl)Phenyl]Amino] Benzoic Acid) within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:F501
b:26.7
occ:0.25
|
F1
|
A:FLF501
|
0.0
|
26.7
|
0.2
|
C7'
|
A:FLF501
|
1.3
|
30.0
|
0.2
|
C5'
|
A:FLF501
|
1.4
|
29.3
|
0.2
|
C6'
|
A:FLF501
|
2.0
|
28.8
|
0.2
|
F2
|
A:FLF501
|
2.1
|
34.3
|
0.2
|
F3
|
A:FLF501
|
2.1
|
34.4
|
0.2
|
C3'
|
A:FLF501
|
2.4
|
29.5
|
0.2
|
C4'
|
A:FLF501
|
2.7
|
29.5
|
0.2
|
C2'
|
A:FLF501
|
2.7
|
27.2
|
0.2
|
O
|
A:ALA108
|
3.3
|
21.1
|
1.0
|
C1'
|
A:FLF501
|
3.3
|
27.3
|
0.2
|
C
|
A:ALA108
|
3.4
|
18.8
|
1.0
|
O
|
A:SER117
|
3.5
|
17.1
|
1.0
|
N
|
A:ALA109
|
3.6
|
14.9
|
1.0
|
C4'
|
A:FLF501
|
3.6
|
27.4
|
0.2
|
CA
|
A:ALA109
|
3.7
|
10.7
|
1.0
|
CB
|
A:ALA108
|
3.7
|
18.1
|
1.0
|
N
|
A:LEU110
|
3.7
|
11.3
|
1.0
|
C
|
A:ALA109
|
3.8
|
13.4
|
1.0
|
C3'
|
A:FLF501
|
3.8
|
31.8
|
0.2
|
N
|
A:THR119
|
3.8
|
12.5
|
1.0
|
CG2
|
A:THR119
|
4.0
|
10.1
|
1.0
|
CA
|
A:THR118
|
4.0
|
15.0
|
1.0
|
C2'
|
A:FLF501
|
4.1
|
29.4
|
0.2
|
C
|
A:SER117
|
4.1
|
15.3
|
1.0
|
C1'
|
A:FLF501
|
4.1
|
26.5
|
0.2
|
CB
|
A:LEU110
|
4.2
|
13.3
|
1.0
|
CA
|
A:ALA108
|
4.2
|
18.5
|
1.0
|
C
|
A:THR118
|
4.2
|
14.8
|
1.0
|
N
|
A:THR118
|
4.3
|
16.8
|
1.0
|
CB
|
A:THR119
|
4.4
|
13.6
|
1.0
|
O
|
A:ALA109
|
4.4
|
15.7
|
1.0
|
N
|
A:FLF501
|
4.5
|
25.9
|
0.2
|
CA
|
A:LEU110
|
4.5
|
12.3
|
1.0
|
C5
|
A:FLF501
|
4.7
|
26.0
|
0.2
|
CB
|
A:SER117
|
4.7
|
18.5
|
1.0
|
CA
|
A:THR119
|
4.7
|
14.3
|
1.0
|
C5'
|
A:FLF501
|
4.8
|
26.9
|
0.2
|
C5
|
A:FLF501
|
4.8
|
27.6
|
0.2
|
N
|
A:FLF501
|
4.9
|
25.5
|
0.2
|
C6'
|
A:FLF501
|
5.0
|
26.8
|
0.2
|
|
Fluorine binding site 2 out
of 12 in 1bm7
Go back to
Fluorine Binding Sites List in 1bm7
Fluorine binding site 2 out
of 12 in the Human Transthyretin (Prealbumin) Complex with Flufenamic Acid (2-[[3-(Trifluoromethyl)Phenyl]Amino] Benzoic Acid)
Mono view
Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 2 of Human Transthyretin (Prealbumin) Complex with Flufenamic Acid (2-[[3-(Trifluoromethyl)Phenyl]Amino] Benzoic Acid) within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:F501
b:37.4
occ:0.25
|
F1
|
A:FLF501
|
0.0
|
37.4
|
0.2
|
C7'
|
A:FLF501
|
1.3
|
33.5
|
0.2
|
C5'
|
A:FLF501
|
2.0
|
26.9
|
0.2
|
F2
|
A:FLF501
|
2.1
|
30.3
|
0.2
|
F3
|
A:FLF501
|
2.1
|
37.3
|
0.2
|
C3'
|
A:FLF501
|
2.4
|
31.8
|
0.2
|
C4'
|
A:FLF501
|
2.5
|
27.4
|
0.2
|
C6'
|
A:FLF501
|
3.1
|
26.8
|
0.2
|
C4'
|
A:FLF501
|
3.2
|
29.5
|
0.2
|
CD2
|
A:LEU110
|
3.2
|
15.0
|
1.0
|
C2'
|
A:FLF501
|
3.3
|
29.4
|
0.2
|
C3'
|
A:FLF501
|
3.7
|
29.5
|
0.2
|
C1'
|
A:FLF501
|
4.1
|
26.5
|
0.2
|
CG
|
A:LEU110
|
4.2
|
15.6
|
1.0
|
C2'
|
A:FLF501
|
4.3
|
27.2
|
0.2
|
CD1
|
A:LEU110
|
4.4
|
13.1
|
1.0
|
C5'
|
A:FLF501
|
4.4
|
29.3
|
0.2
|
C1'
|
A:FLF501
|
4.5
|
27.3
|
0.2
|
CB
|
A:LEU110
|
4.5
|
13.3
|
1.0
|
F2
|
A:FLF501
|
4.6
|
34.3
|
0.2
|
C7'
|
A:FLF501
|
4.7
|
30.0
|
0.2
|
C6'
|
A:FLF501
|
5.0
|
28.8
|
0.2
|
|
Fluorine binding site 3 out
of 12 in 1bm7
Go back to
Fluorine Binding Sites List in 1bm7
Fluorine binding site 3 out
of 12 in the Human Transthyretin (Prealbumin) Complex with Flufenamic Acid (2-[[3-(Trifluoromethyl)Phenyl]Amino] Benzoic Acid)
Mono view
Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 3 of Human Transthyretin (Prealbumin) Complex with Flufenamic Acid (2-[[3-(Trifluoromethyl)Phenyl]Amino] Benzoic Acid) within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:F501
b:34.3
occ:0.25
|
F2
|
A:FLF501
|
0.0
|
34.3
|
0.2
|
C7'
|
A:FLF501
|
1.3
|
30.0
|
0.2
|
C5'
|
A:FLF501
|
1.9
|
29.3
|
0.2
|
C4'
|
A:FLF501
|
1.9
|
29.5
|
0.2
|
F1
|
A:FLF501
|
2.1
|
26.7
|
0.2
|
F3
|
A:FLF501
|
2.1
|
34.4
|
0.2
|
C3'
|
A:FLF501
|
2.4
|
29.5
|
0.2
|
C4'
|
A:FLF501
|
2.8
|
27.4
|
0.2
|
CB
|
A:SER117
|
2.9
|
18.5
|
1.0
|
O
|
A:SER117
|
3.2
|
17.1
|
1.0
|
C6'
|
A:FLF501
|
3.3
|
28.8
|
0.2
|
CB
|
A:LEU110
|
3.3
|
13.3
|
1.0
|
C3'
|
A:FLF501
|
3.3
|
31.8
|
0.2
|
C
|
A:SER117
|
3.4
|
15.3
|
1.0
|
C2'
|
A:FLF501
|
3.6
|
27.2
|
0.2
|
CA
|
A:SER117
|
3.8
|
17.4
|
1.0
|
N
|
A:LEU110
|
3.8
|
11.3
|
1.0
|
N
|
A:THR118
|
3.9
|
16.8
|
1.0
|
OG
|
A:SER117
|
4.0
|
26.6
|
1.0
|
F3
|
A:FLF501
|
4.1
|
37.3
|
0.2
|
CA
|
A:LEU110
|
4.2
|
12.3
|
1.0
|
C7'
|
A:FLF501
|
4.2
|
33.5
|
0.2
|
CD2
|
A:LEU110
|
4.2
|
15.0
|
1.0
|
C5'
|
A:FLF501
|
4.2
|
26.9
|
0.2
|
C1'
|
A:FLF501
|
4.2
|
27.3
|
0.2
|
C2'
|
A:FLF501
|
4.3
|
29.4
|
0.2
|
CA
|
A:THR118
|
4.3
|
15.0
|
1.0
|
CG
|
A:LEU110
|
4.4
|
15.6
|
1.0
|
N
|
A:SER117
|
4.5
|
16.8
|
1.0
|
C
|
A:ALA109
|
4.5
|
13.4
|
1.0
|
F1
|
A:FLF501
|
4.6
|
37.4
|
0.2
|
C
|
A:THR118
|
4.7
|
14.8
|
1.0
|
C1'
|
A:FLF501
|
4.7
|
26.5
|
0.2
|
CA
|
A:ALA109
|
4.8
|
10.7
|
1.0
|
N
|
A:THR119
|
4.8
|
12.5
|
1.0
|
O
|
A:ALA108
|
4.9
|
21.1
|
1.0
|
O
|
A:LEU110
|
5.0
|
17.5
|
1.0
|
C6'
|
A:FLF501
|
5.0
|
26.8
|
0.2
|
|
Fluorine binding site 4 out
of 12 in 1bm7
Go back to
Fluorine Binding Sites List in 1bm7
Fluorine binding site 4 out
of 12 in the Human Transthyretin (Prealbumin) Complex with Flufenamic Acid (2-[[3-(Trifluoromethyl)Phenyl]Amino] Benzoic Acid)
Mono view
Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 4 of Human Transthyretin (Prealbumin) Complex with Flufenamic Acid (2-[[3-(Trifluoromethyl)Phenyl]Amino] Benzoic Acid) within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:F501
b:30.3
occ:0.25
|
F2
|
A:FLF501
|
0.0
|
30.3
|
0.2
|
C7'
|
A:FLF501
|
1.3
|
33.5
|
0.2
|
C5'
|
A:FLF501
|
1.4
|
26.9
|
0.2
|
F1
|
A:FLF501
|
2.1
|
37.4
|
0.2
|
C6'
|
A:FLF501
|
2.1
|
26.8
|
0.2
|
F3
|
A:FLF501
|
2.1
|
37.3
|
0.2
|
C3'
|
A:FLF501
|
2.4
|
31.8
|
0.2
|
C4'
|
A:FLF501
|
2.7
|
27.4
|
0.2
|
C2'
|
A:FLF501
|
2.8
|
29.4
|
0.2
|
C1'
|
A:FLF501
|
3.5
|
26.5
|
0.2
|
C4'
|
A:FLF501
|
3.7
|
29.5
|
0.2
|
C3'
|
A:FLF501
|
3.8
|
29.5
|
0.2
|
C2'
|
A:FLF501
|
4.1
|
27.2
|
0.2
|
C1'
|
A:FLF501
|
4.2
|
27.3
|
0.2
|
N
|
A:FLF501
|
4.6
|
25.5
|
0.2
|
C5'
|
A:FLF501
|
4.8
|
29.3
|
0.2
|
N
|
A:FLF501
|
4.9
|
25.9
|
0.2
|
C6'
|
A:FLF501
|
5.0
|
28.8
|
0.2
|
|
Fluorine binding site 5 out
of 12 in 1bm7
Go back to
Fluorine Binding Sites List in 1bm7
Fluorine binding site 5 out
of 12 in the Human Transthyretin (Prealbumin) Complex with Flufenamic Acid (2-[[3-(Trifluoromethyl)Phenyl]Amino] Benzoic Acid)
Mono view
Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 5 of Human Transthyretin (Prealbumin) Complex with Flufenamic Acid (2-[[3-(Trifluoromethyl)Phenyl]Amino] Benzoic Acid) within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:F501
b:34.4
occ:0.25
|
F3
|
A:FLF501
|
0.0
|
34.4
|
0.2
|
C7'
|
A:FLF501
|
1.3
|
30.0
|
0.2
|
C5'
|
A:FLF501
|
2.0
|
29.3
|
0.2
|
F1
|
A:FLF501
|
2.1
|
26.7
|
0.2
|
F2
|
A:FLF501
|
2.1
|
34.3
|
0.2
|
C3'
|
A:FLF501
|
2.4
|
29.5
|
0.2
|
C4'
|
A:FLF501
|
2.5
|
29.5
|
0.2
|
C6'
|
A:FLF501
|
2.9
|
28.8
|
0.2
|
C4'
|
A:FLF501
|
3.2
|
27.4
|
0.2
|
C2'
|
A:FLF501
|
3.2
|
27.2
|
0.2
|
CB
|
A:THR119
|
3.2
|
13.6
|
1.0
|
CG2
|
A:THR119
|
3.3
|
10.1
|
1.0
|
N
|
A:THR119
|
3.4
|
12.5
|
1.0
|
C3'
|
A:FLF501
|
3.6
|
31.8
|
0.2
|
C
|
A:THR118
|
3.7
|
14.8
|
1.0
|
C1'
|
A:FLF501
|
3.9
|
27.3
|
0.2
|
CA
|
A:THR119
|
3.9
|
14.3
|
1.0
|
CA
|
A:THR118
|
4.0
|
15.0
|
1.0
|
O
|
A:THR118
|
4.1
|
15.1
|
1.0
|
N
|
A:THR118
|
4.1
|
16.8
|
1.0
|
C2'
|
A:FLF501
|
4.2
|
29.4
|
0.2
|
C
|
A:SER117
|
4.2
|
15.3
|
1.0
|
CB
|
A:SER117
|
4.3
|
18.5
|
1.0
|
O
|
A:SER117
|
4.3
|
17.1
|
1.0
|
OG1
|
A:THR119
|
4.4
|
21.7
|
1.0
|
OG
|
B:SER115
|
4.4
|
23.0
|
1.0
|
C1'
|
A:FLF501
|
4.4
|
26.5
|
0.2
|
C5'
|
A:FLF501
|
4.5
|
26.9
|
0.2
|
O
|
A:ALA108
|
4.5
|
21.1
|
1.0
|
F3
|
A:FLF501
|
4.6
|
37.3
|
0.2
|
C7'
|
A:FLF501
|
4.7
|
33.5
|
0.2
|
CA
|
A:SER117
|
4.9
|
17.4
|
1.0
|
C6'
|
A:FLF501
|
5.0
|
26.8
|
0.2
|
|
Fluorine binding site 6 out
of 12 in 1bm7
Go back to
Fluorine Binding Sites List in 1bm7
Fluorine binding site 6 out
of 12 in the Human Transthyretin (Prealbumin) Complex with Flufenamic Acid (2-[[3-(Trifluoromethyl)Phenyl]Amino] Benzoic Acid)
Mono view
Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 6 of Human Transthyretin (Prealbumin) Complex with Flufenamic Acid (2-[[3-(Trifluoromethyl)Phenyl]Amino] Benzoic Acid) within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:F501
b:37.3
occ:0.25
|
F3
|
A:FLF501
|
0.0
|
37.3
|
0.2
|
C7'
|
A:FLF501
|
1.3
|
33.5
|
0.2
|
C4'
|
A:FLF501
|
2.0
|
27.4
|
0.2
|
C5'
|
A:FLF501
|
2.1
|
26.9
|
0.2
|
F1
|
A:FLF501
|
2.1
|
37.4
|
0.2
|
F2
|
A:FLF501
|
2.1
|
30.3
|
0.2
|
C3'
|
A:FLF501
|
2.4
|
31.8
|
0.2
|
C4'
|
A:FLF501
|
2.8
|
29.5
|
0.2
|
C3'
|
A:FLF501
|
3.4
|
29.5
|
0.2
|
C6'
|
A:FLF501
|
3.4
|
26.8
|
0.2
|
C2'
|
A:FLF501
|
3.6
|
29.4
|
0.2
|
F2
|
A:FLF501
|
4.1
|
34.3
|
0.2
|
C5'
|
A:FLF501
|
4.2
|
29.3
|
0.2
|
C7'
|
A:FLF501
|
4.2
|
30.0
|
0.2
|
CD2
|
A:LEU110
|
4.3
|
15.0
|
1.0
|
C2'
|
A:FLF501
|
4.4
|
27.2
|
0.2
|
C1'
|
A:FLF501
|
4.4
|
26.5
|
0.2
|
F3
|
A:FLF501
|
4.6
|
34.4
|
0.2
|
C1'
|
A:FLF501
|
4.7
|
27.3
|
0.2
|
C6'
|
A:FLF501
|
5.0
|
28.8
|
0.2
|
|
Fluorine binding site 7 out
of 12 in 1bm7
Go back to
Fluorine Binding Sites List in 1bm7
Fluorine binding site 7 out
of 12 in the Human Transthyretin (Prealbumin) Complex with Flufenamic Acid (2-[[3-(Trifluoromethyl)Phenyl]Amino] Benzoic Acid)
Mono view
Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 7 of Human Transthyretin (Prealbumin) Complex with Flufenamic Acid (2-[[3-(Trifluoromethyl)Phenyl]Amino] Benzoic Acid) within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
B:F502
b:27.1
occ:0.25
|
F1
|
B:FLF502
|
0.0
|
27.1
|
0.2
|
C7'
|
B:FLF502
|
1.4
|
29.7
|
0.2
|
C5'
|
B:FLF502
|
1.4
|
28.6
|
0.2
|
C6'
|
B:FLF502
|
2.0
|
29.4
|
0.2
|
F2
|
B:FLF502
|
2.1
|
33.4
|
0.2
|
F3
|
B:FLF502
|
2.1
|
34.2
|
0.2
|
C3'
|
B:FLF502
|
2.4
|
28.3
|
0.2
|
C4'
|
B:FLF502
|
2.6
|
28.8
|
0.2
|
C2'
|
B:FLF502
|
2.8
|
27.1
|
0.2
|
C1'
|
B:FLF502
|
3.4
|
27.7
|
0.2
|
O
|
B:ALA108
|
3.4
|
20.3
|
1.0
|
C
|
B:ALA108
|
3.5
|
17.6
|
1.0
|
O
|
B:SER117
|
3.6
|
19.4
|
1.0
|
C4'
|
B:FLF502
|
3.6
|
27.1
|
0.2
|
N
|
B:ALA109
|
3.6
|
16.9
|
1.0
|
CB
|
B:ALA108
|
3.7
|
19.0
|
1.0
|
CA
|
B:ALA109
|
3.7
|
14.3
|
1.0
|
C3'
|
B:FLF502
|
3.8
|
30.5
|
0.2
|
N
|
B:LEU110
|
3.8
|
13.4
|
1.0
|
N
|
B:THR119
|
3.8
|
15.9
|
1.0
|
C
|
B:ALA109
|
3.8
|
13.4
|
1.0
|
CG2
|
B:THR119
|
3.9
|
12.9
|
1.0
|
CA
|
B:THR118
|
4.0
|
17.8
|
1.0
|
C2'
|
B:FLF502
|
4.0
|
29.4
|
0.2
|
C
|
B:SER117
|
4.1
|
18.1
|
1.0
|
C1'
|
B:FLF502
|
4.1
|
26.2
|
0.2
|
CB
|
B:LEU110
|
4.2
|
15.3
|
1.0
|
C
|
B:THR118
|
4.2
|
18.3
|
1.0
|
CA
|
B:ALA108
|
4.2
|
18.3
|
1.0
|
N
|
B:THR118
|
4.3
|
17.6
|
1.0
|
CB
|
B:THR119
|
4.4
|
14.8
|
1.0
|
O
|
B:ALA109
|
4.5
|
16.7
|
1.0
|
N
|
B:FLF502
|
4.5
|
26.7
|
0.2
|
CA
|
B:LEU110
|
4.6
|
13.2
|
1.0
|
CB
|
B:SER117
|
4.7
|
17.0
|
1.0
|
C5
|
B:FLF502
|
4.7
|
28.3
|
0.2
|
CA
|
B:THR119
|
4.7
|
17.6
|
1.0
|
C5'
|
B:FLF502
|
4.8
|
26.9
|
0.2
|
C5
|
B:FLF502
|
4.8
|
29.2
|
0.2
|
N
|
B:FLF502
|
4.9
|
26.6
|
0.2
|
C6'
|
B:FLF502
|
5.0
|
27.8
|
0.2
|
|
Fluorine binding site 8 out
of 12 in 1bm7
Go back to
Fluorine Binding Sites List in 1bm7
Fluorine binding site 8 out
of 12 in the Human Transthyretin (Prealbumin) Complex with Flufenamic Acid (2-[[3-(Trifluoromethyl)Phenyl]Amino] Benzoic Acid)
Mono view
Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 8 of Human Transthyretin (Prealbumin) Complex with Flufenamic Acid (2-[[3-(Trifluoromethyl)Phenyl]Amino] Benzoic Acid) within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
B:F502
b:37.8
occ:0.25
|
F1
|
B:FLF502
|
0.0
|
37.8
|
0.2
|
C7'
|
B:FLF502
|
1.3
|
33.0
|
0.2
|
C5'
|
B:FLF502
|
2.0
|
26.9
|
0.2
|
F3
|
B:FLF502
|
2.1
|
36.1
|
0.2
|
F2
|
B:FLF502
|
2.1
|
31.2
|
0.2
|
C3'
|
B:FLF502
|
2.4
|
30.5
|
0.2
|
C4'
|
B:FLF502
|
2.4
|
27.1
|
0.2
|
CD2
|
B:LEU110
|
3.0
|
17.4
|
1.0
|
C6'
|
B:FLF502
|
3.1
|
27.8
|
0.2
|
C4'
|
B:FLF502
|
3.2
|
28.8
|
0.2
|
C2'
|
B:FLF502
|
3.3
|
29.4
|
0.2
|
C3'
|
B:FLF502
|
3.7
|
28.3
|
0.2
|
C1'
|
B:FLF502
|
4.1
|
26.2
|
0.2
|
CG
|
B:LEU110
|
4.2
|
17.0
|
1.0
|
C2'
|
B:FLF502
|
4.3
|
27.1
|
0.2
|
CD1
|
B:LEU110
|
4.4
|
14.3
|
1.0
|
C5'
|
B:FLF502
|
4.4
|
28.6
|
0.2
|
F2
|
B:FLF502
|
4.5
|
33.4
|
0.2
|
C1'
|
B:FLF502
|
4.5
|
27.7
|
0.2
|
CB
|
B:LEU110
|
4.6
|
15.3
|
1.0
|
C7'
|
B:FLF502
|
4.7
|
29.7
|
0.2
|
C6'
|
B:FLF502
|
5.0
|
29.4
|
0.2
|
|
Fluorine binding site 9 out
of 12 in 1bm7
Go back to
Fluorine Binding Sites List in 1bm7
Fluorine binding site 9 out
of 12 in the Human Transthyretin (Prealbumin) Complex with Flufenamic Acid (2-[[3-(Trifluoromethyl)Phenyl]Amino] Benzoic Acid)
Mono view
Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 9 of Human Transthyretin (Prealbumin) Complex with Flufenamic Acid (2-[[3-(Trifluoromethyl)Phenyl]Amino] Benzoic Acid) within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
B:F502
b:33.4
occ:0.25
|
F2
|
B:FLF502
|
0.0
|
33.4
|
0.2
|
C7'
|
B:FLF502
|
1.3
|
29.7
|
0.2
|
C4'
|
B:FLF502
|
1.9
|
28.8
|
0.2
|
C5'
|
B:FLF502
|
1.9
|
28.6
|
0.2
|
F3
|
B:FLF502
|
2.1
|
34.2
|
0.2
|
F1
|
B:FLF502
|
2.1
|
27.1
|
0.2
|
C3'
|
B:FLF502
|
2.4
|
28.3
|
0.2
|
C4'
|
B:FLF502
|
2.8
|
27.1
|
0.2
|
CB
|
B:SER117
|
2.9
|
17.0
|
1.0
|
C3'
|
B:FLF502
|
3.3
|
30.5
|
0.2
|
C6'
|
B:FLF502
|
3.3
|
29.4
|
0.2
|
O
|
B:SER117
|
3.3
|
19.4
|
1.0
|
CB
|
B:LEU110
|
3.4
|
15.3
|
1.0
|
C
|
B:SER117
|
3.4
|
18.1
|
1.0
|
C2'
|
B:FLF502
|
3.6
|
27.1
|
0.2
|
CA
|
B:SER117
|
3.8
|
17.4
|
1.0
|
N
|
B:LEU110
|
3.9
|
13.4
|
1.0
|
N
|
B:THR118
|
4.0
|
17.6
|
1.0
|
OG
|
B:SER117
|
4.0
|
25.3
|
1.0
|
F3
|
B:FLF502
|
4.0
|
36.1
|
0.2
|
CD2
|
B:LEU110
|
4.1
|
17.4
|
1.0
|
C7'
|
B:FLF502
|
4.1
|
33.0
|
0.2
|
C5'
|
B:FLF502
|
4.2
|
26.9
|
0.2
|
C2'
|
B:FLF502
|
4.2
|
29.4
|
0.2
|
C1'
|
B:FLF502
|
4.3
|
27.7
|
0.2
|
CA
|
B:LEU110
|
4.3
|
13.2
|
1.0
|
CG
|
B:LEU110
|
4.4
|
17.0
|
1.0
|
CA
|
B:THR118
|
4.4
|
17.8
|
1.0
|
F1
|
B:FLF502
|
4.5
|
37.8
|
0.2
|
N
|
B:SER117
|
4.6
|
16.7
|
1.0
|
C
|
B:ALA109
|
4.7
|
13.4
|
1.0
|
C
|
B:THR118
|
4.7
|
18.3
|
1.0
|
C1'
|
B:FLF502
|
4.7
|
26.2
|
0.2
|
N
|
B:THR119
|
4.8
|
15.9
|
1.0
|
CA
|
B:ALA109
|
4.9
|
14.3
|
1.0
|
C6'
|
B:FLF502
|
5.0
|
27.8
|
0.2
|
|
Fluorine binding site 10 out
of 12 in 1bm7
Go back to
Fluorine Binding Sites List in 1bm7
Fluorine binding site 10 out
of 12 in the Human Transthyretin (Prealbumin) Complex with Flufenamic Acid (2-[[3-(Trifluoromethyl)Phenyl]Amino] Benzoic Acid)
Mono view
Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 10 of Human Transthyretin (Prealbumin) Complex with Flufenamic Acid (2-[[3-(Trifluoromethyl)Phenyl]Amino] Benzoic Acid) within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
B:F502
b:31.2
occ:0.25
|
F2
|
B:FLF502
|
0.0
|
31.2
|
0.2
|
C7'
|
B:FLF502
|
1.4
|
33.0
|
0.2
|
C5'
|
B:FLF502
|
1.4
|
26.9
|
0.2
|
C6'
|
B:FLF502
|
2.1
|
27.8
|
0.2
|
F1
|
B:FLF502
|
2.1
|
37.8
|
0.2
|
F3
|
B:FLF502
|
2.1
|
36.1
|
0.2
|
C3'
|
B:FLF502
|
2.4
|
30.5
|
0.2
|
C4'
|
B:FLF502
|
2.6
|
27.1
|
0.2
|
C2'
|
B:FLF502
|
2.8
|
29.4
|
0.2
|
C1'
|
B:FLF502
|
3.5
|
26.2
|
0.2
|
C4'
|
B:FLF502
|
3.6
|
28.8
|
0.2
|
C3'
|
B:FLF502
|
3.8
|
28.3
|
0.2
|
C2'
|
B:FLF502
|
4.1
|
27.1
|
0.2
|
C1'
|
B:FLF502
|
4.1
|
27.7
|
0.2
|
N
|
B:FLF502
|
4.6
|
26.6
|
0.2
|
C5'
|
B:FLF502
|
4.8
|
28.6
|
0.2
|
N
|
B:FLF502
|
4.9
|
26.7
|
0.2
|
C6'
|
B:FLF502
|
5.0
|
29.4
|
0.2
|
|
Reference:
S.A.Peterson,
T.Klabunde,
H.A.Lashuel,
H.Purkey,
J.C.Sacchettini,
J.W.Kelly.
Inhibiting Transthyretin Conformational Changes That Lead to Amyloid Fibril Formation. Proc.Natl.Acad.Sci.Usa V. 95 12956 1998.
ISSN: ISSN 0027-8424
PubMed: 9789022
DOI: 10.1073/PNAS.95.22.12956
Page generated: Wed Jul 31 10:51:07 2024
|